Consio | $3,300,000 | (Jan 27, 2026)
Orbital(US) | $60,000,000 | (Jan 27, 2026)
Inferact | $150,000,000 | (Jan 27, 2026)
Certified by Founder
Lodge
C the Signs
start up
United Kingdom
- London
- 31/01/2025
- Unknown
- $8,000,000
C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease.
In under 30 seconds, C the Signs can rapidly identify which cancers a patient is at risk of and recommend the most appropriate test or specialist to diagnose their cancer.
Using the latest technology, research and evidence, C the Signs enables healthcare providers to give their patients the best chance of surviving cancer.
- Industry Hospital & Health Care
- Website https://www.cthesigns.com/
- LinkedIn https://www.linkedin.com/company/c-the-signs/
Visitt | $22,000,000 | (Jan 27, 2026)
Cashmere(US) | $5,000,000 | (Jan 27, 2026)
Barnwell Bio | $6,000,000 | (Jan 27, 2026)
Mine(US) | $14,000,000 | (Jan 27, 2026)
Lucend | $3,300,000 | (Jan 27, 2026)
Standard Nuclear | $140,000,000 | (Jan 27, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)